FNDC5 and sarcopenia: For instance, in stroke and neurodegenerative diseases, factors such as systemic inflammation, prolonged immobility, sarcopenia, and overall metabolic dysfunction—all hallmarks of these conditions—could directly suppress the production or release of irisin from muscle tissue.